Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aspen Aerogels (ASPN) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to $52.2 million.

  • Aspen Aerogels' Cost of Revenue fell 2354.28% to $52.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $236.8 million, marking a year-over-year decrease of 469.15%. This contributed to the annual value of $269.8 million for FY2024, which is 4840.84% up from last year.
  • Per Aspen Aerogels' latest filing, its Cost of Revenue stood at $52.2 million for Q3 2025, which was down 2354.28% from $52.7 million recorded in Q2 2025.
  • In the past 5 years, Aspen Aerogels' Cost of Revenue ranged from a high of $76.0 million in Q4 2024 and a low of $3.3 million during Q1 2021
  • For the 5-year period, Aspen Aerogels' Cost of Revenue averaged around $46.2 million, with its median value being $46.9 million (2022).
  • In the last 5 years, Aspen Aerogels' Cost of Revenue crashed by 5675.08% in 2021 and then surged by 111766.13% in 2022.
  • Quarter analysis of 5 years shows Aspen Aerogels' Cost of Revenue stood at $33.1 million in 2021, then skyrocketed by 36.62% to $45.3 million in 2022, then rose by 20.59% to $54.6 million in 2023, then skyrocketed by 39.11% to $76.0 million in 2024, then crashed by 31.25% to $52.2 million in 2025.
  • Its last three reported values are $52.2 million in Q3 2025, $52.7 million for Q2 2025, and $55.9 million during Q1 2025.